News

Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...
Regeneron Pharmaceuticals plans to purchase 23andMe just two months after the genetics company filed for bankruptcy.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology ...